3-4 May: An Antiresdev Steering Committee meeting was held in Stockholm, Sweden.
16-17 June: An Antiresdev Steering Committee meeting was held in Siena, Italy.
1st July: The first formal Periodic Report of the Antiresdev project was submitted to the European Commission, covering all of the achievements and work done in the first 18 months of the project.
5th September: The Antiresdev project was successfully reviewed by the European Commission and an independent reviewer, with the report noting that good progress has been made in the project.
1st-2nd December: An Antiresdev Steering Committee meeting was held in Berne, Switzerland.
14 January: provisional ethics committee approval given to Helperby
19 January: 1st Pyrosequencing meeting, at ACTA, Netherlands. Please check Minutes & Reports for a summary of the meeting.
25 January: Antiresdev partners agree that the next meeting would take place in Siena, Italy, at the Certosa di Pontignano http://www.unisi.it/servizi/certosa/en/certosa.htm) from the 22 to the 24th of April.
01 February: the Antidesrev website goes live - Deliverable 11.1 sent to the Commission
05 February: deadline for the submission of the first informal report
10 February: First progress report sent to all partners and added on to the website
15 March: Helperby Therapeutics receive approval from the national committee (Medicines and Healthcare Products Regulatory Agency) and the local ethical committee for the clinical studies to be carried out in WP#1 and WP#2.
22 - 24 April: Steering Committee meeting in Siena. Agenda
9 - 10 December: Steering Committee meeting in Amsterdam
01 November: Antiresdev official start date
04 November: Antiresdev kick-off meeting, London. Please check Minutes & Reports for a summary of the meeting.
07 December: 1st Microbiologists' meeting in London. Please check Minutes & Reports for a summary of the meeting.
08 December: 1st Microarray meeting in London. Please check Minutes & Reports for a summary of the meeting.